Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lyra Therapeutics
Biotech
CRISPR Tx, Novartis, Cour & more—Chutes & Ladders
CRISPR Tx plucks Sanofi leader for CMO spot. Novartis taps leader for newly created innovation role. Cour finds permanent CMO in Acelyrin alum.
Gabrielle Masson
,
Andrea Park
May 24, 2024 8:30am
Exscientia cuts a quarter of staff while preserving AI pipeline
May 21, 2024 11:17am
Catalent shakes up leadership, taps new CEO—Chutes & Ladders
Jul 8, 2022 9:30am
LianBio inks $325M IPO for pipeline with BMS, BridgeBio, Lyra
Nov 1, 2021 10:00am
Lyra Therapeutics taps LianBio to bring sinusitis med to Asia
Jun 2, 2021 10:51am
Lyra Therapeutics wants a $58M IPO
Mar 9, 2020 8:25am
